Askpot
← Market research

Biopharmaceuticals — Europe market analysis

The global biopharmaceuticals market is expanding steadily, propelled by advances in biologics, increased prevalence of chronic diseases, and rising healthcare expenditures. The sector encompasses therapeutic proteins, monoclonal antibodies, vaccines, and cell and gene therapies, with leading companies investing heavily in R&D to address unmet medical needs. Biopharmaceuticals now account for a significant share of new drug approvals and are central to the treatment of cancer, autoimmune disorders, and rare diseases.

Market

Biopharmaceuticals

Region

Europe

Growth
CAGR 2019 2024

7.2

CAGR 2024 2030 Base

7

CAGR 2024 2030 Downside

4.5

Drivers

Expanding biosimilar uptake, aging population, and supportive regulatory pathways for innovation.

Risks

Budget constraints, slower market access, and increasing price negotiations.

Distribution
Market Size

107500000000

Share

25

Footnotes
line1

1) Market size includes therapeutic proteins, monoclonal antibodies, vaccines, and cell/gene therapies; 2) Base case assumes continued innovation and stable macro environment; downside reflects pricing and access headwinds.

line2

Regional splits based on latest available industry data and current FX; growth rates reflect both developed and emerging market dynamics.

source

Askpot AI Analysis Report 2025